REGISTRO DI GESTIONE DEL RITMO SCIENTIFICO DI BOSTON (SOCRATES) (SOCRATES)
REGISTRO DI GESTIONE DEL RITMO SCIENTIFICO DI BOSTON
SOCRATES is part of Boston Scientific's (BSC) Post-market surveillance system. The implementation of such systems is mandatory per local regulations such as the Regulation '(EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices' or short Medical Device Regulation (MDR). The SOCRATES design is therefore based on the BSC's commitment as well as external regulatory requirements to proactively and systematically gather, record and analyze relevant data on the quality, performance and safety of devices throughout their entire lifetime.
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
SOCRATES is a non-randomized, multisite, single-arm, open-label, global post-market observational data collection per standard of care. While generally of prospective design, a limited retrospective element is allowed for the inclusion of patients for a short period of 10 days after their index procedure.
SOCRATES intends to enroll a number of subjects that will support the analysis of all the individual Post Market Clinical Follow-Up (PMCF) Plans. An average of approximately 100 subjects per year and site on a continuous basis is expected but may vary depending on the needs of individual PMCF Plans. As long as SOCRATES is active, there is no upper limit to the total number of subjects that may be enrolled, and enrollment will be driven by the need to support sample sizes of individual PMCF plans for given products/product groupings supported by SOCRATES.
SOCRATES is designed to be a continuous effort after the data collection commences without a predefined closure timepoint. Data collection and enrollment may be stopped, restarted or finalized per Sponsor discretion.
The expected duration of SOCRATES participation for a subject is dependent on
- the specific lifetime of the device (e.g. the battery usage for pulse generators or continued active use of leads for CRM devices) or
- the necessary timeframe to adequately assess safety and performance of the device based on the residual risk assessed for each device in the associated PMCF plan. Timeframes might e.g. spread from 7 days to one year post procedure for EP. The maximum duration per enrolled subject will consequently vary.
For BSC implantable devices subjects are intended to be followed for the entire time of being implanted with a BSC device to allow data collection over the lifetime of the device(s) as required by applicable regulations. A maximum duration per enrolled subject is not defined, unless locally required. In case a local maximum duration is enforced subjects may be consented again and re-enrolled for continued participation if they are still in scope for SOCRATES. Sites shall ensure continuous data collection without any gaps in case a re-enrollment becomes applicable. Data sets for re-enrolled subjects will be handled as if the subject was continuously enrolled. This process will ensure to meet the requirement of MDR for device manufacturers to collect data over the lifetime of the devices.
Tipo di studio
Tipo di studio
Iscrizione (Stimato)
Iscrizione
Contatti e Sedi
Contatto studio
Contatto studio
- Nome: Maria Paz Lopez-Chicharro
- Numero di telefono: 1-800-227-3422
- Email: maria.lopez-chicharro@bsci.com
Backup dei contatti dello studio
- Nome: Jens B Goetzke, Dipl.Ing.
- Numero di telefono: 1-800-227-3422
- Email: Jens.Goetzke@bsci.com
Luoghi di studio
-
-
-
Jette, Belgio, 1090
- Reclutamento
- Universitair Ziekenhuis Brussel
-
Contatto:
- Carlo de Asmundis, Prof.
-
Yvoir, Belgio, 5530
- Reclutamento
- CHU UCL Namur - Site Godinne
-
Contatto:
- Dominique Blommaert, Prof.
-
-
-
-
Quebec
-
Québec, Quebec, Canada, G1V 4G5
- Reclutamento
- Institut Universitaire de Cardiologie et de Pneumologie de Quebec
-
Contatto:
- Jean-Francois Sarrazin, MD
-
-
-
-
-
Brest, Francia, 29200
- Reclutamento
- CHRU de Brest, Hôpital de la Cavale Blanche
-
Contatto:
- Jacques Mansourati, Prof.
-
Clermont-Ferrand, Francia, 63000
- Reclutamento
- CHRU de Clermont-Ferrand
-
Contatto:
- Romain Eschalier, MD
-
Lomme, Francia, 59462
- Reclutamento
- Hopital Saint Philibert
-
Contatto:
- Aymeric Menet, MD
-
Pau, Francia
- Reclutamento
- CHG de Pau
-
Contatto:
- Hugues Bader, MD
-
Saint-Etienne, Francia, 42055
- Reclutamento
- CHU de Saint-Etienne
-
Contatto:
- Antoine Da Costa, Prof.
-
-
-
-
-
Berlin, Germania, 12687
- Reclutamento
- Unfallkrankenhaus Berlin Marzahn
-
Contatto:
- Corinna Lenz, MD
-
Bochum, Germania, 44791
- Completato
- Augusta Kranken Anstalt GmbH
-
-
-
-
-
Athens, Grecia, 17674
- Reclutamento
- Onassis Cardiac Surgery Center
-
Contatto:
- Michael Ephremidis, MD
-
Athens, Grecia, 11527
- Completato
- General Hospital of Athens "G. Gennimatas"
-
-
-
-
-
Dublin, Irlanda, D07 WKW8
- Reclutamento
- Mater Private Hospital
-
Contatto:
- Gabor Szeplaki, Prof.
-
-
-
-
-
Ramat Gan, Israele, 52621
- Reclutamento
- Sheba Medical Center
-
Contatto:
- Roy Beinart, MD
-
Tel Aviv, Israele, 6423906
- Reclutamento
- Tel Aviv Sourasky Medical Center
-
Contatto:
- Raphael Rosso, Professor
-
Tel Aviv, Israele, 62431
- Reclutamento
- Tel Aviv Sourask Medical Center
-
Contatto:
- Raphael Rosso, Professor
-
-
-
-
-
Modena, Italia, 41124
- Reclutamento
- Policlinico di Modena
-
Contatto:
- Giuseppe Boriani, Prof.
-
Roma, Italia, 00168
- Reclutamento
- Policlinico Universitario Agostino Gemelli
-
Contatto:
- Gemma Pelargonio, MD
-
Roma, Italia, 00169
- Reclutamento
- Policlinico Casilino
-
Contatto:
- Leonardo Calò, MD
-
Roma, Italia, 00186
- Reclutamento
- Ospedale S.G. Calibita Fatebenefratelli - Isola Tiberina
-
Contatto:
- Stefano Bianchi, MD
-
-
-
-
-
London, Regno Unito, EC1A 7BE
- Reclutamento
- St. Bartholomew's Hospital
-
Contatto:
- Ross Hunter, Prof.
-
Manchester, Regno Unito, M13 9WL
- Reclutamento
- Manchester Heart Center
-
Contatto:
- Charles Pearman, MD
-
-
-
-
-
Madrid, Spagna, 28040
- Reclutamento
- Hospital Clinico San Carlos
-
Contatto:
- Nicasio Pérez Castellano, MD
-
San Cristóbal de La Laguna, Spagna, 38320
- Reclutamento
- Hospital Universitario de Canarias
-
Contatto:
- Francisco Bosa Ojeda, MD
-
Santa Cruz de Tenerife, Spagna, 38010
- Reclutamento
- Hospital Nuestra Señora de La Candelaria
-
Contatto:
- Luis A. Acosta, MD
-
Zaragoza, Spagna, 50009
- Reclutamento
- Hospital Universitario Miguel Servet
-
Contatto:
- Antonio Asso Abadía, MD
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
The subjects will be recruited from the general patient population of the participating centers who are
- receiving diagnosis or treatment using a BSC product in scope of SOCRATES and
- fulfilling all inclusion criteria and none of the exclusion criteria.
Descrizione
Inclusion Criteria:
- Subject is willing and capable of providing informed consent and/or to give approval to collect/store/process personal health information by the sponsor or such consent/approval is provided by a legally designated representative, if required by local law or regulation.
- Subject is (one criterion must be fulfilled) a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii. the BSC CRM product implant.
Exclusion Criteria:
- Subject is foreseen not to be followed at the enrolling center for at least 1 year after an implant procedure (CRM) or at least 1 month (EP).
- Subject is receiving diagnosis or therapy by means of any product, that is not approved for commercial use at the time of implant/procedure.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: COHORT
- Prospettive temporali: OTHER
Numero di gruppi/coorti
Coorti e interventi
Gruppo / CoorteGruppo / Coorte |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
BSC Product Use
Subject fulfilling one of the following conditions: a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii.the BSC CRM product implant. |
In the scope of the CRM procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific CRM products/components and combination of those products/components with competitor product(s) per hospital's standard of care. In the scope of the EP procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific Electrophysiology products/components and capital equipment products and combination of those products/components with competitor product(s) per hospital's standard of care. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
System-related complication free rate
Lasso di tempo: From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year
|
Freedom from complications related to system |
From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year
|
|
Rate of product related performance deficiencies per product or product group
Lasso di tempo: CRM implant on day 0; EP procedure on day 0
|
Performance of product/product group at implant/procedure |
CRM implant on day 0; EP procedure on day 0
|
|
Rate of product related performance deficiencies per product or product group
Lasso di tempo: CRM implant on day 0 through the implanted duration up to 10 years
|
Performance of product/product group through the implanted duration |
CRM implant on day 0 through the implanted duration up to 10 years
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Direttore dello studio: Eszter Pais, MD, Boston Scientific Corporation
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Inizio studio
Completamento primario (Stimato)
Completamento primario
Completamento dello studio (Stimato)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- SOCRATES - C2157
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .